Preferred Label : inavolisib;

MeSH synonym : GDC-0077; (2S)-2-((2-((4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl)-5,6-dihydroimidazo(1,2-d)(1,4)benzoxazepin-9-yl)amino)propanamide;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3806073/fr/itovebi-inavolisib-cancer-du-sein-localement-avance-ou-metastatique
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
inavolisib
antineoplastic combined chemotherapy protocols
Fulvestrant/Inavolisib/Palbociclib Regimen
Fulvestrant
palbociclib
Phosphoinositide-3 Kinase Inhibitors
breast neoplasms
adult
HR-positive, HER2-negative locally advanced breast cancer with PIK3CA mutation
HER2/Neu Negative
PIK3CA Gene Mutation
neoplasm recurrence, local
Estrogen Receptor Positive
Locally Advanced Estrogen Receptor-Positive Breast Carcinoma
Phosphatidylinositol-3-kinase (Pi3K) inhibitors
evaluation of the transparency committee

---
https://recalls-rappels.canada.ca/fr/avis-rappel/itovebi-inavolisib-et-risque-acidocetose-potentiellement-mortelle
2025
false
false
false
Canada
French
English
pharmacovigilance note
inavolisib
Phosphoinositide-3 Kinase Inhibitors
canada
administration, oral
ketosis

---
Nous contacter.
11/01/2026


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.